Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.56 |
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.50 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 9/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL168589 | 1.00 | FOLH1 (0.56) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| SCHEMBL165084 | 1.00 | FOLH1 (0.56) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Methane SCHEMBL15135721 | 0.98 | FOLH1 (0.54) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Hydrochloric Acid SCHEMBL2844807 | 0.98 | FOLH1 (0.54) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Hydrochloric Acid SCHEMBL29268897 | 0.98 | FOLH1 (0.54) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Hydrochloric Acid SCHEMBL25283310 | 0.98 | FOLH1 (0.54) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Bromide SCHEMBL6933931 | 0.98 | FOLH1 (0.54) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Hydrochloric Acid SCHEMBL8332033 | 0.98 | FOLH1 (0.54) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| Methane SCHEMBL15135720 | 0.98 | FOLH1 (0.54) | FOLH1GSRRNPEPSLC6A5CPB2 | |
| SCHEMBL31642200 | 0.98 | FOLH1 (0.54) | FOLH1GSRRNPEPSLC6A5CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6982 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745237-A1 | RNAI AGENT FOR INHIBITING EXPRESSION OF KETOHEXOKINASE AND USE THEREOF | YUN HO BIO CO., LTD (CN) | 2026-05-20 | — | — | EP | claimed |
| US-20260116921-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | claimed |
| US-12600699-B2 | Thiosemicarbazates and uses thereof | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2026-04-14 | — | — | US | claimed |
| EP-4720086-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Zealand Pharma A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| EP-4720087-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR | Zealand Pharma A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| EP-4482578-B1 | CRF2 RECEPTOR AGONISTS AND THEIR USE IN THERAPY | CORTERIA PHARMACEUTICALS (FR) | 2025-12-24 | — | — | EP | claimed |
| US-20250361280-A1 | CONJUGATED HEPCIDIN MIMETICS | PROTAGONIST THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | claimed |
| US-20250332264-A1 | GhR-BINDING PEPTIDE AND COMPOSITION COMPRISING SAME | PEPTIDREAM INC (JP) | 2025-10-30 | — | — | US | claimed |
| US-12440570-B2 | Conjugation of MCR1 ligand with cytotoxic drugs for treating skin cancer | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-10-14 | — | — | US | claimed |
| EP-4622991-A2 | SYNTHESIS OF A CYCLIC PEPTIDE | Janssen Pharmaceutica NV (BE) | 2025-10-01 | — | — | EP | claimed |
| WO-1996040759-A1 | ANTIVIRAL PEPTOID COMPOUNDS | NOVARTIS AG (CH) | 1996-12-19 | — | — | WO | claimed |
| US-5514646-A | AND OPTIONALLY AT OTHER POSITIONS; USE TO TREAT HYPERGLYCEMIA | ELI LILLY AND COMPANY | 1996-05-07 | — | — | US | claimed |
| EP-0678522-A1 | Insulin analogs | ELI LILLY AND COMPANY (US) | 1995-10-25 | — | — | EP | claimed |
| EP-0167132-B1 | PROCESS FOR PRODUCING L-ISOLEUCINE BY FERMENTATION | AJINOMOTO CO., INC. (JP) | 1992-01-02 | — | — | EP | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| EP-0383472-A2 | Insulin analogs | ELI LILLY AND COMPANY (US) | 1990-08-22 | — | — | EP | claimed |
| CN-1044820-A | insulin analogues | LILLY CO ELI (US) | 1990-08-22 | — | — | CN | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | claimed |
| EP-0167132-A2 | Process for producing l-isoleucine by fermentation | AJINOMOTO CO., INC. (JP) | 1986-01-08 | — | — | EP | claimed |